Research Article

Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata

Table 3

Mean IL-15 and TNF-α levels according to case group characteristics.

VariablesIL-15 (pg/mL) mean ± SD valueTNF-α (pg/mL) mean ± SD value

Age (years)
 <200.94 ± 0.60.06968.47 ± 83.40.202
 20–392.19 ± 2.536.18 ± 21.5
 ≥407.9 ± 16.325.8 ± 6.5
Gender
 Male1.68 ± 2.40.50739.07 ± 22.50.277
 Female2.95 ± 8.060.04 ± 80.7
Duration of disease (months)
 <61.9 ± 2.50.32638.64 ± 25.50.568
 6–121.03 ± 0.7851.56 ± 32.7
 >124.75 ± 11.465.43 ± 110.7
Family history
 Positive0.75 ± 0.390.11148.91 ± 18.10.914
 Negative2.78 ± 6.7350.43 ± 68.1
Previous history
 Positive1.7 ± 2.90.57744.21 ± 28.20.607
 Negative2.61 ± 6.952.51 ± 70.2
Other body area involvement
 Yes0.66 ± 0.050.09329.9 ± 5.40.056
 No2.49 ± 6.351.84 ± 63.7
Exclamation mark
 Yes1.65 ± 2.10.47860.31 ± 73.90.092
 No3.55 ± 9.632.62 ± 18.5
Pull test
 Positive1.57 ± 2.00.43256.54 ± 70.30.145
 Negative4.27 ± 10.934.33 ± 20.7
Nail change
 Yes0.65 ± 0.110.09148.51 ± 27.60.894
 No2.87 ± 6.850.61 ± 68.3
Types of alopecia areata
 Multilocularis1.68 ± 2.10.45847.7 ± 30.70.021
 Unilocularis5.4 ± 12.827.57 ± 11.0
 Universalis1.3 ± 1.032.23 ± 8.2
 Totalis1.6 ± 0147.3 ± 200.6